Beaned: Fatal forty DDI: Diltiazem, tacrolimus, CYP3A4, P-glycoprotein

Matthew Hart; Michael P. Hutchens

doi:10.1007/978-1-4614-7495-1_154

Beaned: Fatal forty DDI: Diltiazem, tacrolimus, CYP3A4, P-glycoprotein

Matthew Hart, Michael P. Hutchens

Anesthesiology and Perioperative Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This case discusses the pharmacokinetic interaction of tacrolimus and diltiazem, including to tacrolimus toxicity. Tacrolimus is a cytochrome P450 3A4 and intestinal P-glycoprotein substrate and diltiazem is an inhibitor.

Original language	English (US)
Title of host publication	A Case Approach to Perioperative Drug-Drug Interactions
Publisher	Springer New York
Pages	693-695
Number of pages	3
ISBN (Electronic)	9781461474951
ISBN (Print)	9781461474944
DOIs	https://doi.org/10.1007/978-1-4614-7495-1_154
State	Published - Sep 15 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-7495-1_154

Cite this

@inbook{0ea62d5a71724734bf13e59162f653e9,

title = "Beaned: Fatal forty DDI: Diltiazem, tacrolimus, CYP3A4, P-glycoprotein",

abstract = "This case discusses the pharmacokinetic interaction of tacrolimus and diltiazem, including to tacrolimus toxicity. Tacrolimus is a cytochrome P450 3A4 and intestinal P-glycoprotein substrate and diltiazem is an inhibitor.",

author = "Matthew Hart and Hutchens, {Michael P.}",

year = "2015",

month = sep,

day = "15",

doi = "10.1007/978-1-4614-7495-1_154",

language = "English (US)",

isbn = "9781461474944",

pages = "693--695",

booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",

publisher = "Springer New York",

}

TY - CHAP

T1 - Beaned

T2 - Fatal forty DDI: Diltiazem, tacrolimus, CYP3A4, P-glycoprotein

AU - Hart, Matthew

AU - Hutchens, Michael P.

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This case discusses the pharmacokinetic interaction of tacrolimus and diltiazem, including to tacrolimus toxicity. Tacrolimus is a cytochrome P450 3A4 and intestinal P-glycoprotein substrate and diltiazem is an inhibitor.

AB - This case discusses the pharmacokinetic interaction of tacrolimus and diltiazem, including to tacrolimus toxicity. Tacrolimus is a cytochrome P450 3A4 and intestinal P-glycoprotein substrate and diltiazem is an inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=84955412861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955412861&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_154

DO - 10.1007/978-1-4614-7495-1_154

M3 - Chapter

AN - SCOPUS:84955412861

SN - 9781461474944

SP - 693

EP - 695

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -

Beaned: Fatal forty DDI: Diltiazem, tacrolimus, CYP3A4, P-glycoprotein

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this